The global transplantation market size was estimated to be USD 16.31 billion in 2023 and is expected to reach at USD 44.6 billion by 2033 with a CAGR of 9.57% during the forecast period 2023-2033. Increasing demand for novel tissue & organ transplantation for the treatment of organ failure, surge in unhealthy dietary habits, alcohol consumption, lack of exercise, & drug abuse, rising introduction of technologically advanced products, growing number of tissue banks, increasing prevalence of acute diseases, rising government initiatives, growing development of technologically advanced tissue product, rise in regulatory approvals of innovative products, and surge in launch of novel tissue products are some of the key factors boosting the market growth.
Surge in launch of novel tissue products is predicted to boost the market growth during the forecast period. For instance, in August 2021, AlloSource introduced the AlloMend Ultra-Thick Acellular Dermal Matrix (ADM), aiming to develop advanced cellular and tissue products that aid surgeons in effectively healing their patients.
By Product, Tissue products was the highest revenue-grossing segment in the global transplantation market in 2022 owing to the surge in number of transplantation procedures such as cochlear, bone marrow, heart valves, & orthopaedic soft tissues, rising focus on new product development, growing investment in research & development activities by medical devices companies. For instance, in June 2022, Arthrex Inc provided funding and support for a soft tissue injury research project carried out in partnership between the Orthopaedic Research and Education Foundation (OREF) and the Orthopaedic Trauma Association (OTA). Additionally, Immunosuppressive drugs is predicted to grow at fastest CAGR during the forecast period owing to the increasing usage of these drugs to prevent post-transplant tissue or organ rejection, growing prevalence of chronic diseases.
By Application, Tissue transplantation was the highest revenue-grossing segment in the global transplantation market in 2022 owing to the growing number of burn & accident cases and surge in replacement of cornea, skin, bones, tendons, nerves, heart valves, & veins procedures. Additionally, Organ transplantation is predicted to grow at fastest CAGR during the forecast period owing to the rising number of organ transplantations, surge in repetitive purchase of immunosuppressants, increasing advancement in transplantation technology, growing launch of new products. For instance, in November 2020, Lupin has introduced a generic version of the immunosuppressant drug Tacrolimus in the U.S. market. The drug is used for preventing organ rejection in allogeneic liver, kidney, and heart transplant patients.
By End-user, Hospitals was the highest revenue-grossing segment in the global transplantation market in 2022 owing to the increasing number of organ & tissue transplant procedures conducted at hospitals, rising healthcare infrastructure, most of these facilities have access to clear databases that may be used to check on the availability of organs for quick medical action, and growing adoption of advanced technologies for transplant procedures. For instance, In April 2023, In Spain, a group of surgeons accomplished the world's first robotic lung transplant using a cutting-edge method that involves the use of a robot named Da Vinci. Additionally, Transplant Centres is predicted to grow at fastest CAGR during the forecast period owing to the rising number of transplant centres, increasing transplantation procedures, growing number of healthcare centres, surge in government initiatives to encourage organ donation.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising demand & supply of organs including liver, kidneys, & heart for transplantation procedures, increasing initiatives by governments and NGOs to encourage people to donate organs & save lives, growing healthcare facilities, presence of leading biotechnology & medical devices companies, surge in the number of organ donations, and rising collaborations within market players. For instance, in October 2021, TransMedics and Dalton Pharma Services have entered into a manufacturing agreement for the OCS Liver System. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing research & development activities on stem cells to develop in-vitro tissue & organs, growing healthcare infrastructure, surge in number of transplant procedures, and rising initiatives by major market players. For instance, in October 2022, Plexision has expanded its operations internationally by setting up a reference laboratory in Hyderabad, India. This facility will provide a wide range of tests for transplant recipients, including personalized transplant diagnostic tests that predict rejection and viral infections. Additionally, the laboratory will offer services such as drug level monitoring, pharmacogenomics, and genetic testing.
Surge in launch of novel tissue products is predicted to boost the market growth during the forecast period. For instance, in August 2021, AlloSource introduced the AlloMend Ultra-Thick Acellular Dermal Matrix (ADM), aiming to develop advanced cellular and tissue products that aid surgeons in effectively healing their patients.
By Product, Tissue products was the highest revenue-grossing segment in the global transplantation market in 2022 owing to the surge in number of transplantation procedures such as cochlear, bone marrow, heart valves, & orthopaedic soft tissues, rising focus on new product development, growing investment in research & development activities by medical devices companies. For instance, in June 2022, Arthrex Inc provided funding and support for a soft tissue injury research project carried out in partnership between the Orthopaedic Research and Education Foundation (OREF) and the Orthopaedic Trauma Association (OTA). Additionally, Immunosuppressive drugs is predicted to grow at fastest CAGR during the forecast period owing to the increasing usage of these drugs to prevent post-transplant tissue or organ rejection, growing prevalence of chronic diseases.
By Application, Tissue transplantation was the highest revenue-grossing segment in the global transplantation market in 2022 owing to the growing number of burn & accident cases and surge in replacement of cornea, skin, bones, tendons, nerves, heart valves, & veins procedures. Additionally, Organ transplantation is predicted to grow at fastest CAGR during the forecast period owing to the rising number of organ transplantations, surge in repetitive purchase of immunosuppressants, increasing advancement in transplantation technology, growing launch of new products. For instance, in November 2020, Lupin has introduced a generic version of the immunosuppressant drug Tacrolimus in the U.S. market. The drug is used for preventing organ rejection in allogeneic liver, kidney, and heart transplant patients.
By End-user, Hospitals was the highest revenue-grossing segment in the global transplantation market in 2022 owing to the increasing number of organ & tissue transplant procedures conducted at hospitals, rising healthcare infrastructure, most of these facilities have access to clear databases that may be used to check on the availability of organs for quick medical action, and growing adoption of advanced technologies for transplant procedures. For instance, In April 2023, In Spain, a group of surgeons accomplished the world's first robotic lung transplant using a cutting-edge method that involves the use of a robot named Da Vinci. Additionally, Transplant Centres is predicted to grow at fastest CAGR during the forecast period owing to the rising number of transplant centres, increasing transplantation procedures, growing number of healthcare centres, surge in government initiatives to encourage organ donation.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising demand & supply of organs including liver, kidneys, & heart for transplantation procedures, increasing initiatives by governments and NGOs to encourage people to donate organs & save lives, growing healthcare facilities, presence of leading biotechnology & medical devices companies, surge in the number of organ donations, and rising collaborations within market players. For instance, in October 2021, TransMedics and Dalton Pharma Services have entered into a manufacturing agreement for the OCS Liver System. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the increasing research & development activities on stem cells to develop in-vitro tissue & organs, growing healthcare infrastructure, surge in number of transplant procedures, and rising initiatives by major market players. For instance, in October 2022, Plexision has expanded its operations internationally by setting up a reference laboratory in Hyderabad, India. This facility will provide a wide range of tests for transplant recipients, including personalized transplant diagnostic tests that predict rejection and viral infections. Additionally, the laboratory will offer services such as drug level monitoring, pharmacogenomics, and genetic testing.
Segmentation: Transplantation Market Report 2022 - 2033
Transplantation Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
- Immunosuppressive Drugs
- Preservation Solution
- Tissue Products
Transplantation Market Analysis & Forecast by Application 2022 - 2033 (Revenue USD Bn)
- Organ Transplantation
- Tissue Transplantation
Transplantation Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Transplant Centres
- Hospitals
- Others
Transplantation Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Transplantation Market: Product Estimates & Trend Analysis
8. Transplantation Market: Application Estimates & Trend Analysis
9. Transplantation Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Transplantation Market
12. Europe Global Transplantation Market
13. Asia Pacific Global Transplantation Market
14. Latin America Global Transplantation Market
15. MEA Global Transplantation Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Novartis AG
- Abbvie Inc
- Zimmer Biomet
- Medtronic
- Arthrex Inc.
- Strykers
- Amnio Technology
- BiolifeSolutions Inc
- 21st Century Medicine
- Veloxis Pharmaceutical
- Orthofix Medical
- Teva Pharmaceuticals
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 16.31 Billion |
| Forecasted Market Value ( USD | $ 44.6 Billion |
| Compound Annual Growth Rate | 9.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 12 |
